Journal of Pain and Symptom Management
Volume 25, Issue 1 , Pages 9-18 , January 2003

Description and Predictors of Direct and Indirect Costs of Pain Reported by Cancer Patients

  • Barry V Fortner, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Barry Fortner, PhD, Psychology and Cancer Symptom Research, West Clinic, 100 North Humphreys Blvd., Memphis, TN 38120, USA
    • West Cancer Clinic, Memphis, TN USA
    • ,
  • Gail Demarco, PhD

      Affiliations

    • Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL USA
    • ,
  • Gordon Irving, MD

      Affiliations

    • Swedish Pain Management Center, Swedish Medical Center, Seattle, WA USA
    • ,
  • Jeri Ashley, RN, MSN, AOCN, CCRC

      Affiliations

    • West Cancer Clinic, Memphis, TN USA
    • ,
  • Ginny Keppler, RN, BSN, OCN

      Affiliations

    • Rocky Mountain Cancer Center, Denver, CO USA
    • ,
  • Jana Chavez, RN

      Affiliations

    • Oncology Center, Orange, CA, USA
    • ,
  • Jana Munk, BS

      Affiliations

    • Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL USA

,Accepted 8 March 2002.

References 

  1. Jacox A, Carr DB, Payne R, et al.  Management of cancer pain. Clinical practice guideline no. 9. Rockville, MD: Agency for Health Care Policy and Research; 1994;
  2. Bonica J. Cancer pain. In:  Bonica J editors. The management of pain, vol.1. 2nd ed. Philadelphia: Lea and Febiger; 1990;p. 400–414
  3. Portenoy RK. Cancer pain. Epidemiology and syndromes. Cancer. 1989;63(11 Suppl):2298–2307
  4. Cleeland C. The impact of pain on the patient with cancer. Cancer. 1984;54:2635–2641
  5. Ahles TA, Blanchard EB, Ruckdeschel JC. The multidimensional nature of cancer-related pain. Pain. 1983;17(3):277–288
  6. Daut RL, Cleeland CS. The prevalence and severity of pain in cancer. Cancer. 1982;50(9):1913–1918
  7. Derogatis LR, Morrow GR, Fetting J, et al.  The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249(6):751–757
  8. Portenoy RK, Kornblith AB, Wong G, et al.  Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms. Cancer. 1994;74(3):907–915
  9. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain (characteristics and impact in patients with cancer pain). Pain. 1999;81(1-2):129–134
  10. Chandler S, Payne R. Economics of unrelieved cancer pain. Am J Hospice Palliative Care. 1998;15(4):223–226
  11. Ferrell B. Cost issues surrounding the treatment of cancer related pain. J Pharm Care Pain Symptom Control. 1993;1(1):9–23
  12. Ferrell B, Schaffner M. Pharmacoeconomics and medical outcomes in pain management. Sem Anesth. 1997;16(2):152–159
  13. Ferrell BR, Rhiner M. Use of technology in the management of cancer pain. J Pharm Care Pain Symptom Control. 1994;2(1):17–34
  14. American Cancer Society. Costs of Cancer. http://www2.cancer.org/cid/506.00/index.htm.
  15. Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96(1):102–109
  16. Brown ML. The national economic burden of cancer (an update). J Natl Cancer Inst. 1990;82(23):1811–1814
  17. Moore K. Out-of-pocket expenditures of outpatients receiving chemotherapy. Oncol Nurs For. 1998;25(9):1615–1622
  18. Hillner BE, McDonald MK, Desch CE, et al.  Costs of care associated with non-small-cell lung cancer in a commercially insured cohort. J Clin Oncol. 1998;16(4):1420–1424
  19. Stevens RA, Ghazi SM. Routes of opioid analgesic therapy in the management of cancer pain. Cancer Control. 2000;7(2):132–141
  20. Goughnour BR, Arkinstall WW. Potential cost-avoidance with oral extended-release morphine sulfate tablets versus morphine sulfate solution. Am J Hosp Pharm. 1991;48(1):101–104
  21. Ferrell BR, Griffith H. Cost issues related to pain management (report from the Cancer Pain Panel of the Agency for Health Care Policy and Research). J Pain Symptom Manage. 1994;9(4):221–234
  22. Kwan JW. Use of infusion devices for epidural or intrathecal administration of spinal opioids. Am J Hosp Pharm. 1990;47(8 Suppl):S18–S23
  23. Bedder MD, Burchiel K, Larson A. Cost analysis of two implantable narcotic delivery systems. J Pain Symptom Manage. 1991;6(6):368–373
  24. Zhukovsky DS, Gorowski E, Hausdorff J, et al.  Unmet analgesic needs in cancer patients. J Pain Symptom Manage. 1995;10(2):113–119
  25. Grant M, Ferrell BR, Rivera LM, et al.  Unscheduled readmissions for uncontrolled symptoms. A health care challenge for nurses. Nurs Clin North Am. 1995;30(4):673–682
  26. Stommel M, Given CW, Given BA. The cost of cancer home care to families. Cancer. 1993;71(5):1867–1874
  27. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983;17(2):197–210
  28. Ferrell BR. The technology of pain relief. Nurs Econ. 1993;11(1):52–54
  29. Williams RM. Distribution of emergency department costs. Ann Emergency Med. 1996;28(6):671–676
  30. Williams RM. The costs of visits to emergency departments. New Engl J Med. 1996;334(10):642–646
  31. Doolittle GC, Harmon A, Williams A, et al.  A cost analysis of a tele-oncology practice. J Telemedicine Telecare. 1997;3(Suppl 1):20–22
  32. Cardinale V. Drug topics red book. Montvale, NJ: Medical Economics Company, Inc; 2000;
  33. Portenoy RK, Hagen NA. Breakthrough pain (definition, prevalence and characteristics). Pain. 1990;41:273–282
  34. Blom G. Statistical estimates and transformed beta-variables. New York: John Wiley and Sons; 1958;
  35. Serlin RC, Mendoza TR, Nakamura Y, et al.  When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61(2):277–284
  36. U. S. Bureau of the Census. Population Profile of the United State: 1997. Washington, DC: U. S. Government Printing Office, 1998.
  37. Risberg T, Kaasa S, Wist E, et al.  Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. Eur J Cancer. 1997;33(4):575–580
  38. Oneschuk D, Fennell L, Hanson J, et al.  The use of complementary medications by cancer patients attending an outpatient pain and symptom clinic. J Palliat Care. 1998;14(4):21–26
  39. Miller M, Boyer MJ, Butow PN, et al.  The use of unproven methods of treatment by cancer patients. Frequency, expectations and cost. Support Care Cancer. 1998;6(4):337–347
  40. Holland JC. Use of alternative medicine—a marker for distress?. N Engl J Med. 1999;340(22):1758–1759
  41. Benbassat J, Taragin M. Hospital readmissions as a measure of quality of health care (advantages and limitations). Arch Intern Med. 2000;160(8):1074–1081
  42. Jennett B. High technology medicine (Benefits and burdens). New York: Oxford University Press; 1986;
  43. Cox BG, Cohen SB. Methodological issues for health care surveys. New York: Marcel Dekker; 1985;
  44. Lansing JB, Morgan JN. Economic survey methods. Ann Arbor: University of Michigan Press; 1971;

PII: S0885-3924(02)00597-3

Journal of Pain and Symptom Management
Volume 25, Issue 1 , Pages 9-18 , January 2003

Article Tools